Filing metadata

Accession number
0001209191-22-020067
Form type
Form 4
Filer
VYNE Therapeutics Inc.
CIK
CIK 1566044
Filed
Mar 18, 2022
Reporting period
Mar 17, 2022
Description
Insider transaction

Explore SEC Filings Hub